Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Lipoxin A5 (LXA5) is produced by enzymatic transformation of EPA by leukocytes.1 LXA5 slowly contracts pulmonary parenchymal strips from guinea pig with similar potency to that of LXA4 and LXB4.2 However, LXA5 does not exert the vasodilatory effects on aortic smooth muscle exhibited by LXA4 and LXB4.2
WARNING This product is not for human or veterinary use.
1. Lipoxene: A new group of trihydroxy pentaenes of eicosapentaenoic acid derived from porcine leukocytes. Biochem. Biophys. Res. Commun. 126(2), 763-772 (1985).
2. Pharmacologic profile of lipoxins A5 and B5: new biologically active eicosanoids. Eur. J. Pharmacol. 163, 55-60 (1989).
Analytical strategy for oxylipin annotation by combining chemical derivatization-
Pulmonary infection induces persistent, pathogen-
Development of an optimized LC-